PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, announces that the Company will be participating at Cantor Fitzgerald’s 2nd Annual Healthcare Conference taking place July 12-13, 2016 in New York City. Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics, will deliver the corporate presentation at 2:00 p.m. Eastern time on July 12th.
